Jobs / United States / Astrazeneca Pharmaceuticals Lp
Analytics Associate Director, US Oncology
Astrazeneca Pharmaceuticals Lp · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles1 certified filing for “Associate Director, Oncology Portfolio Analytics” (Management Analysts) in MD: $157k–$157k, median $157k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Are you ready to turn complex data into insights that shape oncology strategy and improve commercial performance? As Associate Director, Analytics, U.S. Oncology, you will lead commercial analytics within the U.S. Oncology portfolio, helping teams maximize inline brands and prepare for new launches. You will partner with Marketing and cross-functional colleagues to frame critical business questions and deliver innovative, evidence-based answers in collaboration with Market Research, Data Science, Forecasting, Finance, Market Access, and Data Management. Key Accountabilities • Partner with stakeholders to define strategic business questions, align priorities, and translate analytical findings into clear, actionable recommendations. • Lead advanced analytics using complex internal and external healthcare data to evaluate brand performance drivers, disease states, patient journeys, and customer behavior. • Serve as a data and analytics expert, ensuring appropriate methods, data interpretation, quality, governance, and compliance while advancing innovative tools and best practices. • Scope, prioritize, and manage multiple analytics projects, balancing business value, timelines, resources, risks, and delivery by internal teams and external agencies. • Build trusted stakeholder relationships, communicate insights effectively to senior leaders, and coach junior analytics colleagues to strengthen collaboration and delivery quality. This role reports to the Franchise Analytics Director and sits within the Analytics, Data & Reporting function in U.S. Oncology Business Excellence department. The team partners with the U.S. Oncology commercial organization to improve strategic and operational decisions through objective insights, analytics, and performance reporting. This position is based in US - Gaithersburg Essential Skills and Experience • Bachelor’s degree with a preference for a quantitative field. • At least 5 years of experience in analytics, statistics, or a related field, including at least 3 years in the pharmaceutical, biotechnology, or biopharmaceutical consulting sector. • At least 5 years of experience analyzing large, complex healthcare datasets, including claims and electronic health record data. • Demonstrated ability to translate ambiguous business questions into analytical plans and decision-ready recommendations. • Ability to communicate complex analytical concepts clearly to stakeholders. • At least 2 years of experience providing day-to-day direction to internal or external analytics team members. Preferred Skills and Experience • Advanced degree in a quantitative, scientific, or business discipline. • Commercial analytics experience within oncology. • Experience with predictive modeling, machine learning, or other advanced analytical methods. • Proficiency in SQL, R, Python, or comparable analytical tools. • Experience overseeing business intelligence and data visualization solutions. • Proven project leadership skills, including prioritization, resource coordination, and risk management. Working at AstraZeneca When we put unexpected teams in the same room, we spark bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace, and challenge perceptions. That’s why we work, on average, a minimum of three days per week from the office. We balance the expectation of being in the office while respecting individual local flexibility. Why AstraZeneca? At AstraZeneca's Oncology Business Unit, we are fundamentally changing the way cancer is treated through innovation. We turn our pipeline into reality for more patients, bringing novel and transformative medicines to market. Our pipeline is one of the deepest and broadest in th